Trials / Sponsors / Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Year Autism Spectrum Disorder, Autism | Phase 2 | 2022-01-25 |
| Completed | Safety of L1-79 in Adolescent and Adult Males With Autism Autism | Phase 2 | 2016-10-01 |